期刊文献+

External Gastric Balloon in Obesity Treatment

External Gastric Balloon in Obesity Treatment
下载PDF
导出
摘要 Obesity is an important and chronic disease. It is known that obesity is closely related with many chronic disorders. Thus, well knowledge about effects of obesity and its alternative treatments is important for determining ideal treatment of obesity and its complications. In this study the authors tried to use a different method that is called EGB (External Gastric Balloon) for obesity treatment which is completely non-invasive. 91 patients were observed, including 47 of study group and 44 of control group. In the study group patients used a corset for 2.51 ± 1.07 months without hypocaloric diet and exercise. And during this time average weight loss was 6.08 kg. On the other hand, the control group was planned to take 1400-2400 kcal/day diet (approximately 1695.45 ± 256.95 kcal/day). Patients in the control group diet for a period 4.48 ±2.17 months. Average weight loss was 6.06 kg. Patients in the study group weight loss with corset usage time between positive and statistically significant relationship at the level of 38.6% was observed (P 〈 0.05). The higher weight loss can be seen with long corset using period. A statistically significant relationship between duration of the diet in the control group patients and weight loss was not seen (P 〉 0.05).
出处 《Journal of Life Sciences》 2013年第5期475-482,共8页 生命科学(英文版)
分类号 Q [生物学]
  • 相关文献

参考文献2

二级参考文献21

  • 1史轶蘩,潘长玉,高妍,樊继援,邹大进,刘志民,刘超,李红,谷卫,李秀钧,林丽香,翁建平.奥利司他在中国超重或肥胖2型糖尿病患者中的疗效分析[J].中华内分泌代谢杂志,2004,20(5):403-407. 被引量:15
  • 2马冠生,李艳平,武阳丰,翟凤英,崔朝辉,胡小琪,栾德春,胡永华,杨晓光.1992至2002年间中国居民超重率和肥胖率的变化[J].中华预防医学杂志,2005,39(5):311-315. 被引量:247
  • 3Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord, 1992,16:397-415.
  • 4Williamson DF. International weight loss:patterns in the general population and its association with morbidity and mortality . Int J Obes Relat Metab Disord, 1997, 21 Suppl 1 : S14-S19.
  • 5Lissner L, Heitmann BL. Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr, 1995, 49: 79-90.
  • 6Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr, 2005,82:222S -225S.
  • 7Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther, 1996,18 : 1006-1035.
  • 8Padwal R, Li SK, Lau DC. Long term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev, 2003, 4 : CD004094.
  • 9Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004,27 : 155-161.
  • 10Ballinger A, Peikin SR. Orlistat: its current status as an antiobesity drug. Eur J Pharmacol, 2002,440 : 109-117.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部